Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.
about
Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness.Women's lived experiences of learning to live with osteoporosis: a longitudinal qualitative study.Use of osteoporosis medications after hospitalization for hip fracture: a cross-national studyEarly (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study.Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.Benefits of investment into modern medicines in Central-Eastern European countries.Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost.Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.Incidence and Predictors of Multiple Fractures Despite High Adherence to Oral Bisphosphonates: A Binational Population-Based Cohort Study.Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients.Risk factors for fracture among current, persistent users of bisphosphonates.Mortality toll due to avoiding estrogen therapy in hysterectomized women: estimates for 2002 – 2011.Economic impact of medication non-adherence by disease groups: a systematic review.Cost and health care resource use associated with noncompliance with oral bisphosphonate therapy: an analysis using Danish health registries.Effect of improved medication adherence on health care costs in osteoporosis patients
P2860
Q30819137-7096BB1B-F77A-4964-B130-8DD7093D7F1AQ30841438-F74FBE10-FBF8-47D3-8FA1-56F99CF6408FQ35554696-916D46B9-1F11-425E-90D1-79F1CDF82683Q35707347-1EE9180E-8384-4360-8656-4E24493E4D56Q37147488-8C44923B-E37F-437B-AAE2-DC869D89760CQ38172291-5A4BC267-62D3-4354-B90E-607ECB91439BQ38788967-622ABEB6-DCFF-403D-821A-FFDC155CCE30Q38836075-98F8226B-9313-46D8-AD36-2AA1F853FA97Q40736476-CC87267E-CA9E-46D4-A430-850ECCC83139Q42678027-7BFE880B-E2D5-4FBB-81FB-25425F666A51Q44430151-99F434D1-4BDD-4CF1-83DC-F9EC80A0598FQ46425362-9D15CCA5-B664-4011-B5A9-F409B1DC8DB3Q47555825-D4DC9D63-1201-4356-A52E-44FB7774EB7BQ48167255-4FD091AB-D62F-4446-A163-F143A4DEE5D2Q57215181-82F96245-8B41-4893-8BAE-09FE8642FA48
P2860
Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Association between refill com ...... ing national health databases.
@en
Association between refill com ...... ing national health databases.
@nl
type
label
Association between refill com ...... ing national health databases.
@en
Association between refill com ...... ing national health databases.
@nl
prefLabel
Association between refill com ...... ing national health databases.
@en
Association between refill com ...... ing national health databases.
@nl
P2860
P1476
Association between refill com ...... sing national health databases
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-013-2365-Y
P407
P577
2013-04-20T00:00:00Z
P5875
P6179
1011739892